These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1079405)

  • 1. Prolonged bleeding times with factor IX and XI deficiency von Willebrand's syndromes.
    Brody JI
    Am J Med Sci; 1975; 269(1):19-24. PubMed ID: 1079405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II. Application in bleeding disorders.
    Janzarik H; Heinrich D; Bödeker RH; Lasch HG
    Blut; 1988 Sep; 57(3):111-6. PubMed ID: 3262003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in women with von Willebrand's disease or factor XI deficiency.
    Kadir RA; Lee CA; Sabin CA; Pollard D; Economides DL
    Br J Obstet Gynaecol; 1998 Mar; 105(3):314-21. PubMed ID: 9532993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited bleeding disorders.
    Blanchette VS; Sparling C; Turner C
    Baillieres Clin Haematol; 1991 Apr; 4(2):291-332. PubMed ID: 1912663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding time after aspirin in disorders of intrinsic clotting.
    Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
    N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined severe factor XI deficiency and von Willebrand's disease.
    Chediak J; Lambert E; Johnson EI; Telfer MC
    Am J Clin Pathol; 1980 Jul; 74(1):108-14. PubMed ID: 6772018
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced tissue factor (thromboplastin) activity in von Willebrand's disease.
    Zacharski LR; Rosenstein R; Cornwell GG; Davis WM; McIntyre OR
    Am J Med; 1974 Jul; 57(1):102-7. PubMed ID: 4546024
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
    Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis.
    Tavori S; Brenner B; Tatarsky I
    Thromb Haemost; 1990 Feb; 63(1):36-8. PubMed ID: 2111046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of von Willebrand's disease.
    Aledort LM
    Mayo Clin Proc; 1991 Aug; 66(8):841-6. PubMed ID: 1907343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of heat-treated factor VIII concentrates in von Willebrand's disease and related disorders: studies in platelet-type von Willebrand's disease].
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Takizawa S; Tamura M; Yamaguchi T; Wada K; Shibata A
    Rinsho Ketsueki; 1987 Dec; 28(12):2117-24. PubMed ID: 3133507
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.